Paul A. Goepfert - Publications

University of Alabama, Birmingham, Birmingham, AL, United States 
Microbiology Biology

99 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Du VY, Bansal A, Carlson J, Salazar-Gonzalez JF, Salazar MG, Ladell K, Gras S, Josephs TM, Heath SL, Price DA, Rossjohn J, Hunter E, Goepfert PA. HIV-1-Specific CD8 T Cells Exhibit Limited Cross-Reactivity during Acute Infection. Journal of Immunology (Baltimore, Md. : 1950). PMID 26983786 DOI: 10.4049/jimmunol.1502411  0.36
2016 Chan CN, Trinité B, Lee CS, Mahajan S, Anand A, Wodarz D, Sabbaj S, Bansal A, Goepfert PA, Levy DN. HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells. Retrovirology. 13: 1. PMID 26728316 DOI: 10.1186/s12977-015-0234-9  0.36
2015 Walsh SR, Moodie Z, Fiore-Gartland AJ, Morgan C, Wilck MB, Hammer SM, Buchbinder SP, Kalams SA, Goepfert PA, Mulligan MJ, Keefer MC, Baden LR, Swann EM, Grant S, Ahmed H, et al. Vaccination with heterologous HIV envelope sequences and heterologous adenovirus vectors increases T cell responses to conserved regions (HVTN 083). The Journal of Infectious Diseases. PMID 26475930 DOI: 10.1093/infdis/jiv496  0.36
2015 Erdmann N, Du VY, Carlson J, Schaefer M, Jureka A, Sterrett S, Yue L, Dilernia D, Lakhi S, Tang J, Sidney J, Gilmour J, Allen S, Hunter E, Heath S, ... ... Goepfert PA, et al. HLA Class-II Associated HIV Polymorphisms Predict Escape from CD4+ T Cell Responses. Plos Pathogens. 11: e1005111. PMID 26302050 DOI: 10.1371/journal.ppat.1005111  0.36
2015 Seu L, Sabbaj S, Duverger A, Wagner F, Anderson JC, Davies E, Wolschendorf F, Willey CD, Saag MS, Goepfert P, Kutsch O. Stable Phenotypic Changes of the Host T Cells Are Essential to the Long-Term Stability of Latent HIV-1 Infection. Journal of Virology. 89: 6656-72. PMID 25878110 DOI: 10.1128/JVI.00571-15  0.36
2015 Bet A, Maze EA, Bansal A, Sterrett S, Gross A, Graff-Dubois S, Samri A, Guihot A, Katlama C, Theodorou I, Mesnard JM, Moris A, Goepfert PA, Cardinaud S. The HIV-1 antisense protein (ASP) induces CD8 T cell responses during chronic infection. Retrovirology. 12: 15. PMID 25809376 DOI: 10.1186/s12977-015-0135-y  0.36
2015 Claiborne DT, Prince JL, Scully E, Macharia G, Micci L, Lawson B, Kopycinski J, Deymier MJ, Vanderford TH, Nganou-Makamdop K, Ende Z, Brooks K, Tang J, Yu T, Lakhi S, ... ... Goepfert PA, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proceedings of the National Academy of Sciences of the United States of America. 112: E1480-9. PMID 25730868 DOI: 10.1073/pnas.1421607112  0.36
2015 Stoddard MB, Li H, Wang S, Saeed M, Andrus L, Ding W, Jiang X, Learn GH, von Schaewen M, Wen J, Goepfert PA, Hahn BH, Ploss A, Rice CM, Shaw GM. Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4. Mbio. 6: e02518. PMID 25714714 DOI: 10.1128/mBio.02518-14  0.36
2015 Yue L, Pfafferott KJ, Baalwa J, Conrod K, Dong CC, Chui C, Rong R, Claiborne DT, Prince JL, Tang J, Ribeiro RM, Cormier E, Hahn BH, Perelson AS, Shaw GM, ... ... Goepfert P, et al. Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV-1 recipients. Plos Pathogens. 11: e1004565. PMID 25569444 DOI: 10.1371/journal.ppat.1004565  0.36
2014 Overton ET, Sterrett S, Westfall AO, Kahan SM, Burkholder G, Zajac AJ, Goepfert PA, Bansal A. Effects of atorvastatin and pravastatin on immune activation and T-cell function in antiretroviral therapy-suppressed HIV-1-infected patients. Aids (London, England). 28: 2627-31. PMID 25574964 DOI: 10.1097/QAD.0000000000000475  0.36
2014 Frey SE, Peiperl L, McElrath MJ, Kalams S, Goepfert PA, Keefer MC, Baden LR, Lally MA, Mayer K, Blattner WA, Harro CD, Hammer SM, Gorse GJ, Hural J, Tomaras GD, et al. Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants. Clinical and Vaccine Immunology : Cvi. 21: 1589-99. PMID 25253665 DOI: 10.1128/CVI.00450-14  0.36
2014 Overton ET, Goepfert PA, Cunningham P, Carter WA, Horvath J, Young D, Strayer DR. Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans. Vaccine. 32: 5490-5. PMID 25128802 DOI: 10.1016/j.vaccine.2014.07.078  0.36
2014 Carlson JM, Schaefer M, Monaco DC, Batorsky R, Claiborne DT, Prince J, Deymier MJ, Ende ZS, Klatt NR, DeZiel CE, Lin TH, Peng J, Seese AM, Shapiro R, Frater J, ... ... Goepfert P, et al. HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneck. Science (New York, N.Y.). 345: 1254031. PMID 25013080 DOI: 10.1126/science.1254031  0.36
2014 Williams LD, Amatya N, Bansal A, Sabbaj S, Heath SL, Sereti I, Goepfert PA. Immune activation is associated with CD8 T cell interleukin-21 production in HIV-1-infected individuals. Journal of Virology. 88: 10259-63. PMID 24942568 DOI: 10.1128/JVI.00764-14  0.36
2014 Merino AM, Dugast AS, Wilson CM, Goepfert PA, Alter G, Kaslow RA, Tang J. KIR2DS4 promotes HIV-1 pathogenesis: new evidence from analyses of immunogenetic data and natural killer cell function. Plos One. 9: e99353. PMID 24901871 DOI: 10.1371/journal.pone.0099353  0.36
2014 Bowers NL, Helton ES, Huijbregts RPH, Goepfert PA, Heath SL, Hel Z. Immune Suppression by Neutrophils in HIV-1 Infection: Role of PD-L1/PD-1 Pathway Plos Pathogens. 10. PMID 24626392 DOI: 10.1371/journal.ppat.1003993  0.36
2014 Bet A, Sterrett S, Sato A, Bansal A, Goepfert PA. Characterization of T-cell responses to cryptic epitopes in recipients of a noncodon-optimized HIV-1 vaccine. Journal of Acquired Immune Deficiency Syndromes (1999). 65: 142-50. PMID 24442221 DOI: 10.1097/QAI.0b013e3182a9917e  0.36
2014 Goepfert PA, Elizaga ML, Seaton K, Tomaras GD, Montefiori DC, Sato A, Hural J, DeRosa SC, Kalams SA, McElrath MJ, Keefer MC, Baden LR, Lama JR, Sanchez J, Mulligan MJ, et al. Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles. The Journal of Infectious Diseases. 210: 99-110. PMID 24403557 DOI: 10.1093/infdis/jiu003  0.36
2014 Kaslow RA, Erbelding EJ, Goepfert PA. Human immunodeficiency viruses types 1 and 2 Viral Infections of Humans: Epidemiology and Control. 1001-1062. DOI: 10.1007/978-1-4899-7448-8_43  0.36
2013 Merino AM, Sabbaj S, Easlick J, Goepfert P, Kaslow RA, Tang J. Dimorphic HLA-B signal peptides differentially influence HLA-E- and natural killer cell-mediated cytolysis of HIV-1-infected target cells. Clinical and Experimental Immunology. 174: 414-23. PMID 23952339 DOI: 10.1111/cei.12187  0.36
2013 Murphy MK, Yue L, Pan R, Boliar S, Sethi A, Tian J, Pfafferot K, Karita E, Allen SA, Cormier E, Goepfert PA, Borrow P, Robinson JE, Gnanakaran S, Hunter E, et al. Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth. Plos Pathogens. 9: e1003173. PMID 23468623 DOI: 10.1371/journal.ppat.1003173  0.36
2013 Yan J, Sabbaj S, Bansal A, Amatya N, Shacka JJ, Goepfert PA, Heath SL. HIV-specific CD8+ T cells from elite controllers are primed for survival. Journal of Virology. 87: 5170-81. PMID 23449791 DOI: 10.1128/JVI.02379-12  0.36
2013 Huijbregts RP, Helton ES, Michel KG, Sabbaj S, Richter HE, Goepfert PA, Hel Z. Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms. Endocrinology. 154: 1282-95. PMID 23354099 DOI: 10.1210/en.2012-1850  0.36
2013 Yue L, Prentice HA, Farmer P, Song W, He D, Lakhi S, Goepfert P, Gilmour J, Allen S, Tang J, Kaslow RA, Hunter E. Cumulative impact of host and viral factors on HIV-1 viral-load control during early infection. Journal of Virology. 87: 708-15. PMID 23115285 DOI: 10.1128/JVI.02118-12  0.36
2012 Wei Q, Moldoveanu Z, Huang WQ, Alexander RC, Goepfert PA, Mestecky J. Comparative Evaluation of HIV-1 Neutralization in External Secretions and Sera of HIV-1-Infected Women. The Open Aids Journal. 6: 293-302. PMID 23346267 DOI: 10.2174/1874613601206010293  0.36
2012 Prince JL, Claiborne DT, Carlson JM, Schaefer M, Yu T, Lahki S, Prentice HA, Yue L, Vishwanathan SA, Kilembe W, Goepfert P, Price MA, Gilmour J, Mulenga J, Farmer P, et al. Role of transmitted Gag CTL polymorphisms in defining replicative capacity and early HIV-1 pathogenesis. Plos Pathogens. 8: e1003041. PMID 23209412 DOI: 10.1371/journal.ppat.1003041  0.36
2012 Janes H, Frahm N, DeCamp A, Rolland M, Gabriel E, Wolfson J, Hertz T, Kallas E, Goepfert P, Friedrich DP, Corey L, Mullins JI, McElrath MJ, Gilbert P. MRKAd5 HIV-1 Gag/Pol/Nef vaccine-induced T-cell responses inadequately predict distance of breakthrough HIV-1 sequences to the vaccine or viral load. Plos One. 7: e43396. PMID 22952672 DOI: 10.1371/journal.pone.0043396  0.36
2012 Li H, Stoddard MB, Wang S, Blair LM, Giorgi EE, Parrish EH, Learn GH, Hraber P, Goepfert PA, Saag MS, Denny TN, Haynes BF, Hahn BH, Ribeiro RM, Perelson AS, et al. Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing. Plos Pathogens. 8: e1002880. PMID 22927816 DOI: 10.1371/journal.ppat.1002880  0.36
2012 Zhang M, Clausell A, Robinson T, Yin J, Chen E, Johnson L, Weiss G, Sabbaj S, Lowe RM, Wagner FH, Goepfert PA, Kutsch O, Cron RQ. Host factor transcriptional regulation contributes to preferential expression of HIV type 1 in IL-4-producing CD4 T cells. Journal of Immunology (Baltimore, Md. : 1950). 189: 2746-57. PMID 22875803 DOI: 10.4049/jimmunol.1103129  0.36
2012 Lee HY, Giorgi EE, Keele BF, Gaschen B, Athreya GS, Salazar-Gonzalez JF, Pham KT, Goepfert PA, Kilby JM, Saag MS, Delwart EL, Busch MP, Hahn BH, Shaw GM, Korber BT, et al. Corrigendum to "Modeling sequence evolution in acute HIV-1 infection" [J. Theor. Biol. 261 (2009) 341-360] Journal of Theoretical Biology. 297: 187. DOI: 10.1016/j.jtbi.2011.12.010  0.36
2011 Sabbaj S, Hel Z, Richter HE, Mestecky J, Goepfert PA. Menstrual blood as a potential source of endometrial derived CD3+ T cells. Plos One. 6: e28894. PMID 22174921 DOI: 10.1371/journal.pone.0028894  0.36
2011 Liao HX, Chen X, Munshaw S, Zhang R, Marshall DJ, Vandergrift N, Whitesides JF, Lu X, Yu JS, Hwang KK, Gao F, Markowitz M, Heath SL, Bar KJ, Goepfert PA, et al. Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated Journal of Experimental Medicine. 208: 2237-2249. PMID 21987658 DOI: 10.1084/jem.20110363  0.36
2011 Gnanakaran S, Bhattacharya T, Daniels M, Keele BF, Hraber PT, Lapedes AS, Shen T, Gaschen B, Krishnamoorthy M, Li H, Decker JM, Salazar-Gonzalez JF, Wang S, Jiang C, Gao F, ... ... Goepfert PA, et al. Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections. Plos Pathogens. 7: e1002209. PMID 21980282 DOI: 10.1371/journal.ppat.1002209  0.36
2011 Koblin BA, Casapia M, Morgan C, Qin L, Wang ZM, Defawe OD, Baden L, Goepfert P, Tomaras GD, Montefiori DC, McElrath MJ, Saavedra L, Lau CY, Graham BS. Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trial. Plos One. 6: e24517. PMID 21931737 DOI: 10.1371/journal.pone.0024517  0.36
2011 Churchyard GJ, Morgan C, Adams E, Hural J, Graham BS, Moodie Z, Grove D, Gray G, Bekker LG, McElrath MJ, Tomaras GD, Goepfert P, Kalams S, Baden LR, Lally M, et al. A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204). Plos One. 6: e21225. PMID 21857901 DOI: 10.1371/journal.pone.0021225  0.36
2011 Akinsiku OT, Bansal A, Sabbaj S, Heath SL, Goepfert PA. Interleukin-2 production by polyfunctional HIV-1-specific CD8 T cells is associated with enhanced viral suppression. Journal of Acquired Immune Deficiency Syndromes (1999). 58: 132-40. PMID 21637109 DOI: 10.1097/QAI.0b013e318224d2e9  0.36
2011 Sabbaj S, Pass RF, Goepfert PA, Pichon S. Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women. The Journal of Infectious Diseases. 203: 1534-41. PMID 21592981 DOI: 10.1093/infdis/jir138  0.36
2011 Goepfert PA, Elizaga ML, Sato A, Qin L, Cardinali M, Hay CM, Hural J, DeRosa SC, DeFawe OD, Tomaras GD, Montefiori DC, Xu Y, Lai L, Kalams SA, Baden LR, et al. Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles. The Journal of Infectious Diseases. 203: 610-9. PMID 21282192 DOI: 10.1093/infdis/jiq105  0.36
2011 Keefer MC, Frey SE, Elizaga M, Metch B, De Rosa SC, Barroso PF, Tomaras G, Cardinali M, Goepfert P, Kalichman A, Philippon V, McElrath MJ, Jin X, Ferrari G, Defawe OD, et al. A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects. Vaccine. 29: 1948-58. PMID 21216311 DOI: 10.1016/j.vaccine.2010.12.104  0.36
2011 Williams LD, Bansal A, Sabbaj S, Heath SL, Song W, Tang J, Zajac AJ, Goepfert PA. Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers. Journal of Virology. 85: 2316-24. PMID 21159862 DOI: 10.1128/JVI.01476-10  0.36
2011 Heath SL, Sabbaj S, Bansal A, Kilby JM, Goepfert PA. CD8 T-cell proliferative capacity is compromised in primary HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes (1999). 56: 213-21. PMID 21079516 DOI: 10.1097/QAI.0b013e3181ff2aba  0.36
2010 Subramanya S, Armant M, Salkowitz JR, Nyakeriga AM, Haridas V, Hasan M, Bansal A, Goepfert PA, Wynn KK, Ladell K, Price DA, N M, Kan-Mitchell J, Shankar P. Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNA. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 2028-37. PMID 20648001 DOI: 10.1038/mt.2010.148  0.36
2010 Hersperger AR, Pereyra F, Nason M, Demers K, Sheth P, Shin LY, Kovacs CM, Rodriguez B, Sieg SF, Teixeira-Johnson L, Gudonis D, Goepfert PA, Lederman MM, Frank I, Makedonas G, et al. Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. Plos Pathogens. 6: e1000917. PMID 20523897 DOI: 10.1371/journal.ppat.1000917  0.36
2010 Bansal A, Carlson J, Yan J, Akinsiku OT, Schaefer M, Sabbaj S, Bet A, Levy DN, Heath S, Tang J, Kaslow RA, Walker BD, Ndung'u T, Goulder PJ, Heckerman D, ... ... Goepfert PA, et al. CD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcription. The Journal of Experimental Medicine. 207: 51-9. PMID 20065064 DOI: 10.1084/jem.20092060  0.36
2010 Nandi A, Lavine CL, Wang P, Lipchina I, Goepfert PA, Shaw GM, Tomaras GD, Montefiori DC, Haynes BF, Easterbrook P, Robinson JE, Sodroski JG, Yang X. Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1. Virology. 396: 339-48. PMID 19922969 DOI: 10.1016/j.virol.2009.10.044  0.36
2009 Lee HY, Giorgi EE, Keele BF, Gaschen B, Athreya GS, Salazar-Gonzalez JF, Pham KT, Goepfert PA, Kilby JM, Saag MS, Delwart EL, Busch MP, Hahn BH, Shaw GM, Korber BT, et al. Modeling sequence evolution in acute HIV-1 infection. Journal of Theoretical Biology. 261: 341-60. PMID 19660475 DOI: 10.1016/j.jtbi.2009.07.038  0.36
2009 Levesque MC, Moody MA, Hwang KK, Marshall DJ, Whitesides JF, Amos JD, Gurley TC, Allgood S, Haynes BB, Vandergrift NA, Plonk S, Parker DC, Cohen MS, Tomaras GD, Goepfert PA, et al. Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection. Plos Medicine. 6: e1000107. PMID 19582166 DOI: 10.1371/journal.pmed.1000107  0.36
2009 Crawford H, Lumm W, Leslie A, Schaefer M, Boeras D, Prado JG, Tang J, Farmer P, Ndung'u T, Lakhi S, Gilmour J, Goepfert P, Walker BD, Kaslow R, Mulenga J, et al. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients. The Journal of Experimental Medicine. 206: 909-21. PMID 19307327 DOI: 10.1084/jem.20081984  0.36
2009 Harro CD, Robertson MN, Lally MA, O'Neill LD, Edupuganti S, Goepfert PA, Mulligan MJ, Priddy FH, Dubey SA, Kierstead LS, Sun X, Casimiro DR, DiNubile MJ, Shiver JW, Leavitt RY, et al. Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults. Aids Research and Human Retroviruses. 25: 103-14. PMID 19108693 DOI: 10.1089/aid.2008.0212  0.36
2009 Heath SL, Jiyu J, Bansal A, Sabbaj S, Shacka JJ, Goepfert PA. P16-25. HIV specific CTL from elite controllers have a unique survival advantage Retrovirology. 6: P254. DOI: 10.1186/1742-4690-6-S3-P254  0.36
2009 Hersperger AR, Pereyra F, Demers K, Sheth P, Shin LY, Rodriguez B, Sieg SF, Teixeira-Johnson L, Goepfert PA, Lederman MM, Kaul R, Makedonas G, Walker BD, Betts MR. S03-06 OA. Rapid perforin upregulation by CD8 T cells in elite controllers as a correlate of immune-mediated control of HIV replication Retrovirology. 6: O45. DOI: 10.1186/1742-4690-6-S3-O45  0.36
2008 Liu W, Worobey M, Li Y, Keele BF, Bibollet-Ruche F, Guo Y, Goepfert PA, Santiago ML, Ndjango JB, Neel C, Clifford SL, Sanz C, Kamenya S, Wilson ML, Pusey AE, et al. Molecular ecology and natural history of simian foamy virus infection in wild-living chimpanzees. Plos Pathogens. 4: e1000097. PMID 18604273 DOI: 10.1371/journal.ppat.1000097  0.36
2008 Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, Sun C, Grayson T, Wang S, Li H, Wei X, Jiang C, Kirchherr JL, Gao F, Anderson JA, ... ... Goepfert PA, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proceedings of the National Academy of Sciences of the United States of America. 105: 7552-7. PMID 18490657 DOI: 10.1073/pnas.0802203105  0.36
2008 Kilby JM, Lee HY, Hazelwood JD, Bansal A, Bucy RP, Saag MS, Shaw GM, Acosta EP, Johnson VA, Perelson AS, Goepfert PA. Treatment response in acute/early infection versus advanced AIDS: equivalent first and second phases of HIV RNA decline. Aids (London, England). 22: 957-62. PMID 18453855 DOI: 10.1097/QAD.0b013e3282fbd1da  0.36
2008 Bansal A, Jackson B, West K, Wang S, Lu S, Kennedy JS, Goepfert PA. Multifunctional T-cell characteristics induced by a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration. Journal of Virology. 82: 6458-69. PMID 18448544 DOI: 10.1128/JVI.00068-08  0.36
2008 Goepfert PA, Lumm W, Farmer P, Matthews P, Prendergast A, Carlson JM, Derdeyn CA, Tang J, Kaslow RA, Bansal A, Yusim K, Heckerman D, Mulenga J, Allen S, Goulder PJ, et al. Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. The Journal of Experimental Medicine. 205: 1009-17. PMID 18426987 DOI: 10.1084/jem.20072457  0.36
2008 Crawford H, Prado JG, Leslie A, Hué S, Honeyborne I, Reddy S, Van Der Stok M, Mncube Z, Brander C, Rousseau C, Mullins JI, Kaslow R, Goepfert P, Allen S, Hunter E, et al. Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted gag epitope in chronic human immunodeficiency virus type 1 infection (Journal of Virology (2007) 81, 15, (8346-8351)) Journal of Virology. 82: 3161. DOI: 10.1128/JVI.02750-07  0.36
2007 Bansal A, Yue L, Conway J, Yusim K, Tang J, Kappes J, Kaslow RA, Wilson CM, Goepfert PA. Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents. Aids (London, England). 21: 2387-97. PMID 18025875 DOI: 10.1097/QAD.0b013e3282f13823  0.36
2007 Brockman MA, Schneidewind A, Lahaie M, Schmidt A, Miura T, Desouza I, Ryvkin F, Derdeyn CA, Allen S, Hunter E, Mulenga J, Goepfert PA, Walker BD, Allen TM. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. Journal of Virology. 81: 12608-18. PMID 17728232 DOI: 10.1128/JVI.01369-07  0.36
2007 Crawford H, Prado JG, Leslie A, Hué S, Honeyborne I, Reddy S, van der Stok M, Mncube Z, Brander C, Rousseau C, Mullins JI, Kaslow R, Goepfert P, Allen S, Hunter E, et al. Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection. Journal of Virology. 81: 8346-51. PMID 17507468 DOI: 10.1128/JVI.00465-07  0.36
2007 Fu TM, Dubey SA, Mehrotra DV, Freed DC, Trigona WL, Adams-Muhler L, Clair JH, Evans TG, Steigbigel R, Jacobson JM, Goepfert PA, Mulligan MJ, Kalams SA, Rinaldo C, Zhu L, et al. Evaluation of cellular immune responses in subjects chronically infected with HIV type 1. Aids Research and Human Retroviruses. 23: 67-76. PMID 17263635 DOI: 10.1089/aid.2006.0114  0.36
2007 Sabbaj S, Heath SL, Bansal A, Vohra S, Kilby JM, Zajac AJ, Goepfert PA. Functionally competent antigen-specific CD127(hi) memory CD8+ T cells are preserved only in HIV-infected individuals receiving early treatment. The Journal of Infectious Diseases. 195: 108-17. PMID 17152014 DOI: 10.1086/509510  0.36
2007 Yu XG, Lichterfeld M, Chetty S, Williams KL, Mui SK, Miura T, Frahm N, Feeney ME, Tang Y, Pereyra F, Labute MX, Pfafferott K, Leslie A, Crawford H, Allgaier R, ... ... Goepfert PA, et al. Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes. Journal of Virology. 81: 1619-31. PMID 17121793 DOI: 10.1128/JVI.01580-06  0.36
2007 Goepfert PA, Tomaras GD, Horton H, Montefiori D, Ferrari G, Deers M, Voss G, Koutsoukos M, Pedneault L, Vandepapeliere P, McElrath MJ, Spearman P, Fuchs JD, Koblin BA, Blattner WA, et al. Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers. Vaccine. 25: 510-8. PMID 17049679 DOI: 10.1016/j.vaccine.2006.07.050  0.36
2006 Chattopadhyay PK, Price DA, Harper TF, Betts MR, Yu J, Gostick E, Perfetto SP, Goepfert P, Koup RA, De Rosa SC, Bruchez MP, Roederer M. Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry. Nature Medicine. 12: 972-7. PMID 16862156 DOI: 10.1038/nm1371  0.36
2006 Yu J, Chen H, Horton H, Bansal A, McElrath JM, Reichman R, Goepfert P, Jin X. Interleukin-2 reconstitutes defective human immunodeficiency virus (HIV), and cytomegalovirus (CMV) specific CD8+ T cell proliferation in HIV infection. Journal of Medical Virology. 78: 1147-57. PMID 16847956 DOI: 10.1002/jmv.20675  0.36
2006 Turnbull EL, Lopes AR, Jones NA, Cornforth D, Newton P, Aldam D, Pellegrino P, Turner J, Williams I, Wilson CM, Goepfert PA, Maini MK, Borrow P. HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently. Journal of Immunology (Baltimore, Md. : 1950). 176: 6130-46. PMID 16670322  0.36
2006 Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, Lederman MM, Benito JM, Goepfert PA, Connors M, Roederer M, Koup RA. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 107: 4781-9. PMID 16467198 DOI: 10.1182/blood-2005-12-4818  0.36
2006 Bansal A, Gough E, Ritter D, Wilson C, Mulenga J, Allen S, Goepfert PA. Group M-based HIV-1 Gag peptides are frequently targeted by T cells in chronically infected US and Zambian patients. Aids (London, England). 20: 353-60. PMID 16439868 DOI: 10.1097/01.aids.0000206501.16783.67  0.36
2005 Goepfert PA, Horton H, McElrath MJ, Gurunathan S, Ferrari G, Tomaras GD, Montefiori DC, Allen M, Chiu YL, Spearman P, Fuchs JD, Koblin BA, Blattner WA, Frey S, Keefer MC, et al. High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects. The Journal of Infectious Diseases. 192: 1249-59. PMID 16136469 DOI: 10.1086/432915  0.36
2005 Fuller MJ, Hildeman DA, Sabbaj S, Gaddis DE, Tebo AE, Shang L, Goepfert PA, Zajac AJ. Cutting edge: emergence of CD127high functionally competent memory T cells is compromised by high viral loads and inadequate T cell help. Journal of Immunology (Baltimore, Md. : 1950). 174: 5926-30. PMID 15879083  0.36
2005 Betts MR, Exley B, Price DA, Bansal A, Camacho ZT, Teaberry V, West SM, Ambrozak DR, Tomaras G, Roederer M, Kilby JM, Tartaglia J, Belshe R, Gao F, Douek DC, ... ... Goepfert P, et al. Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection. Proceedings of the National Academy of Sciences of the United States of America. 102: 4512-7. PMID 15753288 DOI: 10.1073/pnas.0408773102  0.36
2005 Moore JS, Wu X, Kulhavy R, Tomana M, Novak J, Moldoveanu Z, Brown R, Goepfert PA, Mestecky J. Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals. Aids (London, England). 19: 381-9. PMID 15750391  0.36
2005 Sabbaj S, Ghosh MK, Edwards BH, Leeth R, Decker WD, Goepfert PA, Aldrovandi GM. Breast milk-derived antigen-specific CD8+ T cells: an extralymphoid effector memory cell population in humans. Journal of Immunology (Baltimore, Md. : 1950). 174: 2951-6. PMID 15728507  0.36
2005 Bansal A, Gough E, Sabbaj S, Ritter D, Yusim K, Sfakianos G, Aldrovandi G, Kaslow RA, Wilson CM, Mulligan MJ, Kilby JM, Goepfert PA. CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides. Aids (London, England). 19: 241-50. PMID 15718834  0.36
2004 Mestecky J, Jackson S, Moldoveanu Z, Nesbit LR, Kulhavy R, Prince SJ, Sabbaj S, Mulligan MJ, Goepfert PA. Paucity of antigen-specific IgA responses in sera and external secretions of HIV-type 1-infected individuals. Aids Research and Human Retroviruses. 20: 972-88. PMID 15585085 DOI: 10.1089/0889222042222791  0.36
2004 Ferrari G, Neal W, Ottinger J, Jones AM, Edwards BH, Goepfert P, Betts MR, Koup RA, Buchbinder S, McElrath MJ, Tartaglia J, Weinhold KJ. Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele. Journal of Immunology (Baltimore, Md. : 1950). 173: 2126-33. PMID 15265949 DOI: 10.4049/jimmunol.173.3.2126  0.36
2004 Wright PF, Mestecky J, McElrath MJ, Keefer MC, Gorse GJ, Goepfert PA, Moldoveanu Z, Schwartz D, Spearman PW, El Habib R, Spring MD, Zhu Y, Smith C, Flores J, Weinhold KJ, et al. Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein. The Journal of Infectious Diseases. 189: 1221-31. PMID 15031791 DOI: 10.1086/382088  0.36
2003 Bansal A, Sabbaj S, Edwards BH, Ritter D, Perkins C, Tang J, Szinger JJ, Weiss H, Goepfert PA, Korber B, Wilson CM, Kaslow RA, Mulligan MJ. T cell responses in HIV type 1-infected adolescent minorities share similar epitope specificities with whites despite significant differences in HLA class I alleles. Aids Research and Human Retroviruses. 19: 1017-26. PMID 14678609 DOI: 10.1089/088922203322588378  0.36
2003 Lindemann D, Goepfert PA. The foamy virus envelope glycoproteins Current Topics in Microbiology and Immunology. 277: 111-129. PMID 12908770  0.36
2003 Sabbaj S, Bansal A, Ritter GD, Perkins C, Edwards BH, Gough E, Tang J, Szinger JJ, Korber B, Wilson CM, Kaslow RA, Mulligan MJ, Goepfert PA. Cross-reactive CD8+ T cell epitopes identified in US adolescent minorities. Journal of Acquired Immune Deficiency Syndromes (1999). 33: 426-38. PMID 12869831  0.36
2003 Goepfert PA. Making sense of the HIV immune response. Topics in Hiv Medicine : a Publication of the International Aids Society, Usa. 11: 4-8. PMID 12717044  0.36
2003 Tussey LG, Nair US, Bachinsky M, Edwards BH, Bakari J, Grimm K, Joyce J, Vessey R, Steigbigel R, Robertson MN, Shiver JW, Goepfert PA. Antigen burden is major determinant of human immunodeficiency virus-specific CD8+ T cell maturation state: potential implications for therapeutic immunization. The Journal of Infectious Diseases. 187: 364-74. PMID 12552420 DOI: 10.1086/367707  0.36
2003 Shaw KL, Lindemann D, Mulligan MJ, Goepfert PA. Foamy virus envelope glycoprotein is sufficient for particle budding and release. Journal of Virology. 77: 2338-48. PMID 12551971 DOI: 10.1128/JVI.77.4.2338-2348.2003  0.36
2002 Sabbaj S, Edwards BH, Ghosh MK, Semrau K, Cheelo S, Thea DM, Kuhn L, Ritter GD, Mulligan MJ, Goepfert PA, Aldrovandi GM. Human immunodeficiency virus-specific CD8(+) T cells in human breast milk. Journal of Virology. 76: 7365-73. PMID 12097549 DOI: 10.1128/JVI.76.15.7365-7373.2002  0.36
2002 Edwards BH, Bansal A, Sabbaj S, Bakari J, Mulligan MJ, Goepfert PA. Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. Journal of Virology. 76: 2298-305. PMID 11836408 DOI: 10.1128/jvi.76.5.2298-2305.2002  0.36
2001 Kaslow RA, Rivers C, Tang J, Bender TJ, Goepfert PA, El Habib R, Weinhold K, Mulligan MJ, Clements-Mann ML, Schwartz D, Belshe R, Gorse G, Frey S, Dolin R, Keefer M, et al. Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines Journal of Virology. 75: 8681-8689. PMID 11507213 DOI: 10.1128/JVI.75.18.8681-8689.2001  0.36
2001 Evans TG, McElrath MJ, Matthews T, Montefiori D, Weinhold K, Wolff M, Keefer MC, Kallas EG, Corey L, Gorse GJ, Belshe R, Graham BS, Spearman PW, Schwartz D, Mulligan MJ, ... Goepfert P, et al. QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans. Vaccine. 19: 2080-91. PMID 11228380 DOI: 10.1016/S0264-410X(00)00415-1  0.36
2001 Corey L, Mulligan M, Goepfert P, Sabbaj S, Clements-Mann ML, Harrow C, Schwartz D, Dolin R, Evans T, Keefer M, Belshe R, Gorse G, Frey S, McElrath J, Graham B, et al. Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 env, gag, and pro in combination with RGP120 Journal of Infectious Diseases. 183: 563-570. PMID 11170981 DOI: 10.1086/318523  0.36
2000 Goepfert PA, Bansal A, Edwards BH, Ritter GD, Tellez I, McPherson SA, Sabbaj S, Mulligan MJ. A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon. Journal of Virology. 74: 10249-55. PMID 11024158 DOI: 10.1128/JVI.74.21.10249-10255.2000  0.36
2000 Kilby JM, Goepfert PA, Miller AP, Gnann JW, Sillers M, Saag MS, Bucy RP. Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: A case report. Annals of Internal Medicine. 133: 435-8. PMID 10975961  0.36
2000 Sabbaj S, Mulligan MJ, Hsieh RH, Belshe RB, McGhee JR. Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine. NIAID AIDS Vaccine Evaluation Group. Aids (London, England). 14: 1365-74. PMID 10930151 DOI: 10.1097/00002030-200007070-00009  0.36
2000 Bansal A, Shaw KL, Edwards BH, Goepfert PA, Mulligan MJ. Characterization of the R572T point mutant of a putative cleavage site in human foamy virus Env. Journal of Virology. 74: 2949-54. PMID 10684317 DOI: 10.1128/JVI.74.6.2949-2954.2000  0.36
1999 Goepfert PA, Shaw K, Wang G, Bansal A, Edwards BH, Mulligan MJ. An endoplasmic reticulum retrieval signal partitions human foamy virus maturation to intracytoplasmic membranes Journal of Virology. 73: 7210-7217. PMID 10438808  0.36
1999 Gorse GJ, Corey L, Patel GB, Mandava M, Hsieh RH, Matthews TJ, Walker MC, McElrath MJ, Berman PW, Eibl MM, Belshe RB. HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. Aids Research and Human Retroviruses. 15: 115-32. PMID 10029244 DOI: 10.1089/088922299311547  0.36
1997 Goepfert PA, Shaw KL, Ritter GD, Mulligan MJ. A sorting motif localizes the foamy virus glycoprotein to the endoplasmic reticulum. Journal of Virology. 71: 778-84. PMID 8985416  0.36
1996 Goepfert PA, Ritter J, Peng X, Gbakima AA, Zhang Y, Mulligan MJ. Analysis of West African hunters for foamy virus infections Aids Research and Human Retroviruses. 12: 1725-1730. PMID 8959250  0.36
1995 Goepfert PA, Wang G, Mulligan MJ. Identification of an ER retrieval signal in a retroviral glycoprotein Cell. 82: 543-544. PMID 7664333 DOI: 10.1016/0092-8674(95)90026-8  0.36
1995 Hamill RJ, Houston ED, Georghiou PR, Wright CE, Koza MA, Cadle RM, Goepfert PA, Lewis DA, Zenon GJ, Clarridge JE. An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Annals of Internal Medicine. 122: 762-6. PMID 7536401  0.36
Show low-probability matches.